HIND
NASDAQ · Pharmaceuticals
Vyome Holdings Inc
$2.29
-0.03 (-1.29%)
Open$2.28
Previous Close$2.32
Day High$2.34
Day Low$2.25
52W High$305.00
52W Low—
Volume—
Avg Volume50.5K
Market Cap16.00M
P/E Ratio—
EPS$-183.14
SectorPharmaceuticals
Analyst Ratings
Strong Buy
7 analysts
Price Target
+734.9% upside
Current
$2.29
$2.29
Target
$19.12
$19.12
$13.94
$19.12 avg
$23.15
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 11.03B | 13.17B | 5.84M |
| Net Income | -9,827,389,831 | -10,553,216,618 | 1.21M |
| Profit Margin | -89.1% | -84.6% | 20.8% |
| EBITDA | -9,763,987,518 | -11,067,638,876 | 1.81M |
| Free Cash Flow | — | — | 575.3K |
| Rev Growth | -16.2% | -16.2% | -9.0% |
| Debt/Equity | — | — | 0.79 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |